Stephen Chapman
Net worth: 24 M $ as of 31/05/2026
Net worth: 24 M $ as of 31/05/2026
Currently, Stephen Chapman occupies the position of President, Chief Executive Officer & Director at Natera, Inc. In his past career Mr. Chapman held the position of Regional Manager at Genzyme Corp. and Principal at the University of California, Los Angeles. He received an undergraduate degree from the University of California, Los Angeles.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NATERA, INC. 0.08% | 04/06/2026 | 108,743 ( 0.08% ) | 24 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| NATERA, INC. | Chief Executive Officer | 02/01/2019 |
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2010 |
American Clinical Laboratories, Inc.
American Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical and clinical labs | Director/Board Member | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
American Clinical Laboratories, Inc.
American Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical and clinical labs | Health Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Natera, Inc.
Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
Select your edition
All financial news and data tailored to specific country editions